Jessica Tassan
Stock Analyst at Piper Sandler
(1.90)
# 3,175
Out of 4,964 analysts
81
Total ratings
36.07%
Success rate
-6.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $3.70 | +8.11% | 12 | Aug 27, 2025 | |
| PINC Premier | Maintains: Neutral | $24 → $28 | $26.03 | +7.57% | 8 | Aug 25, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $72.20 | +19.12% | 3 | Aug 15, 2025 | |
| OSCR Oscar Health | Maintains: Neutral | $14 → $13 | $17.11 | -24.02% | 6 | Aug 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $69.15 | -0.22% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $295.93 | -8.09% | 4 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $353 → $317 | $300.82 | +5.38% | 8 | Jul 30, 2025 | |
| HNGE Hinge Health | Initiates: Overweight | $41 | $57.07 | -28.16% | 1 | Jun 16, 2025 | |
| AMWL American Well | Reiterates: Neutral | $10 → $8 | $7.00 | +14.29% | 3 | May 23, 2025 | |
| CI The Cigna Group | Maintains: Overweight | $348 → $374 | $296.67 | +26.07% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $71.34 | +3.73% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $16.09 | +30.52% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.75 | +54.94% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $16 | $9.91 | +61.45% | 3 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $31 → $33 | $32.26 | +2.29% | 5 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $32.91 | +112.70% | 4 | Aug 2, 2023 |
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $3.70
Upside: +8.11%
Premier
Aug 25, 2025
Maintains: Neutral
Price Target: $24 → $28
Current: $26.03
Upside: +7.57%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $72.20
Upside: +19.12%
Oscar Health
Aug 14, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $17.11
Upside: -24.02%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $69.15
Upside: -0.22%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $295.93
Upside: -8.09%
UnitedHealth Group
Jul 30, 2025
Maintains: Overweight
Price Target: $353 → $317
Current: $300.82
Upside: +5.38%
Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $41
Current: $57.07
Upside: -28.16%
American Well
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $7.00
Upside: +14.29%
The Cigna Group
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $296.67
Upside: +26.07%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $71.34
Upside: +3.73%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $16.09
Upside: +30.52%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.75
Upside: +54.94%
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $9.91
Upside: +61.45%
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $32.26
Upside: +2.29%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $32.91
Upside: +112.70%